18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected NonSmall Cell Lung Cancer
Kotaro Higashi, MD1,
Yoshimichi Ueda, MD2,
Yukiko Arisaka, MD1,
Tsutomu Sakuma, MD3,
Yoshihiro Nambu, MD4,
Manabu Oguchi, MD1,
Hiroyasu Seki, MD5,
Suzuka Taki, MD1,
Hisao Tonami, MD1 and
Itaru Yamamoto, MD1
1 Department of Radiology, Kanazawa Medical University, Ishikawa, Japan
2 Department of Pathology, Kanazawa Medical University, Ishikawa, Japan
3 Department of Respiratory Surgery, Kanazawa Medical University, Ishikawa, Japan
4 Division of Respiratory Disease, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan
5 Department of Radiology, Kanazawa Cardiovascular Hospital, Ishikawa, Japan

View larger version (30K):
[in a new window]
|
FIGURE 1. (A) KaplanMeier survival curves of all 57 patients according to SUV of lung cancer. (B) KaplanMeier disease-free survival curves of all 57 patients according to SUV of lung cancer. (C and D) KaplanMeier disease-free survival curves of 46 patients with pathologic stage (pStage) I NSCLC (C) and 38 patients with pStage IA NSCLC (D) according to SUV of lung cancer. Curves reveal clear demarcation, with poor survival or disease-free survival of subjects in high-SUV group.
|
|

View larger version (79K):
[in a new window]
|
FIGURE 2. Patient 37: moderately differentiated adenocarcinoma, 3.5 cm in maximal diameter, pathologic stage IB (T2 N0 M0). (A) CT image shows nodule in right lung. (B) 18F-FDG PET shows faint accumulation in tumor (SUV, 2.12). Patient was alive 53 mo after PET study.
|
|

View larger version (53K):
[in a new window]
|
FIGURE 3. Patient 35: moderately differentiated adenocarcinoma, 2.9 cm in maximal diameter, pathologic stage IA (T1 N0 M0). (A) CT image shows nodule in right lung. (B) 18F-FDG PET shows hot accumulation in tumor (SUV, 5.76). Patient suffered recurrence in brain 27 mo after PET study and died 32 mo after PET study.
|
|
Copyright © 2002 by the Society of Nuclear Medicine.